• Explore /
  • Poster
  • / Clinical outcomes and markers of treatment response in a randomized phase II study of androgen deprivation therapy with or without palbociclib in RB-intact metastatic hormone-sensitive prostate cancer (mHSPC).

Clinical outcomes and markers of treatment response in a randomized phase II study of androgen deprivation therapy with or without palbociclib in RB-intact metastatic hormone-sensitive prostate cancer (mHSPC).

Abstract Poster

Authors

null

Phillip Lee Palmbos

University of Michigan Rogel Cancer Center, Ann Arbor, MI

Phillip Lee Palmbos , Scott A. Tomlins , Stephanie Daignault , Neeraj Agarwal , Przemyslaw Twardowski , Alicia K. Morgans , William Kevin Kelly , Vivek Arora , Emmanuel S. Antonarakis , Javed Siddiqui , Dan Robinson , Karen E. Knudsen , Arul Chinnaiyan , Maha H. A. Hussain

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02059213

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5573)

DOI

10.1200/JCO.2020.38.15_suppl.5573

Abstract #

5573

Poster Bd #

154

Abstract Disclosures

Similar Posters

First Author: Malinda T West

First Author: Laurien Joanna Zeverijn

First Author: Kim N. Chi

Poster

2020 ASCO Virtual Scientific Program

Genomic landscape and immune phenotype of malignant pleural mesothelioma.

Genomic landscape and immune phenotype of malignant pleural mesothelioma.

First Author: Meera Patel